Nuvectis Pharma Inc (NVCT)

Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	14.08%4.68	4.11	5.09	5.77	3.61
Research and Development	14.08%4.68	4.11	5.09	5.77	3.61
Operating Income/Loss	14.97%-7.20	-6.26	-7.62	-7.79	-6.60
	16.03%-7.02	-6.05	-7.31	-7.46	-6.33
Attributable To Parent	16.03%-7.02	-6.05	-7.31	-7.46	-6.33
Available To Common Stockholders, Basic	16.03%-7.02	-6.05	-7.31	-9.89	-6.33
Basic Average Shares	0.26%23.48	23.41	0.46	22.72	21.37
Diluted Average Shares	0.26%23.48	23.41	0.46	22.72	21.37
Basic Earnings Per Share	15.38%-0.30	-0.26	-0.31	-0.44	-0.30
Diluted Earnings Per Share	15.38%-0.30	-0.26	-0.31	-0.44	-0.30